S&P 500

5.222,68

0,16%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Novelion Therapeutics Inc (NVLN)
Novelion Therapeutics Inc (NVLN) Notícias

NVLN

Novelion Therapeutics (NVLN)

Novelion Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:NVLN

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
30/03/2020	17:30	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:NVLN	Novelion Therapeutics Inc
13/02/2020	18:52	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:NVLN	Novelion Therapeutics Inc
21/01/2020	19:24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVLN	Novelion Therapeutics Inc
15/01/2020	19:26	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:NVLN	Novelion Therapeutics Inc
17/12/2019	15:38	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:NVLN	Novelion Therapeutics Inc
12/12/2019	18:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVLN	Novelion Therapeutics Inc
15/11/2019	18:33	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:NVLN	Novelion Therapeutics Inc
08/10/2019	09:10	GlobeNewswire Inc.	Novelion Therapeutics Announces Nasdaq Delisting	NASDAQ:NVLN	Novelion Therapeutics Inc
08/10/2019	09:01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NVLN	Novelion Therapeutics Inc
03/10/2019	19:21	GlobeNewswire Inc.	Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matter...	NASDAQ:NVLN	Novelion Therapeutics Inc
03/10/2019	18:18	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:NVLN	Novelion Therapeutics Inc
27/09/2019	18:01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:NVLN	Novelion Therapeutics Inc
25/09/2019	09:25	GlobeNewswire Inc.	Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers	NASDAQ:NVLN	Novelion Therapeutics Inc
20/09/2019	18:23	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:NVLN	Novelion Therapeutics Inc
11/09/2019	18:50	GlobeNewswire Inc.	Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Ann...	NASDAQ:NVLN	Novelion Therapeutics Inc
30/08/2019	09:02	GlobeNewswire Inc.	Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy Case	NASDAQ:NVLN	Novelion Therapeutics Inc
23/08/2019	18:10	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:NVLN	Novelion Therapeutics Inc
21/08/2019	18:09	GlobeNewswire Inc.	Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq	NASDAQ:NVLN	Novelion Therapeutics Inc
12/08/2019	17:34	GlobeNewswire Inc.	Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019	NASDAQ:NVLN	Novelion Therapeutics Inc
16/07/2019	19:43	GlobeNewswire Inc.	Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition	NASDAQ:NVLN	Novelion Therapeutics Inc
05/07/2019	09:30	GlobeNewswire Inc.	Novelion Therapeutics Receives Delisting Notifications	NASDAQ:NVLN	Novelion Therapeutics Inc
24/06/2019	09:30	GlobeNewswire Inc.	Novelion Therapeutics Responds to Whitefort Capital Petition	NASDAQ:NVLN	Novelion Therapeutics Inc
20/05/2019	23:53	GlobeNewswire Inc.	Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which...	NASDAQ:NVLN	Novelion Therapeutics Inc
07/05/2019	17:18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVLN	Novelion Therapeutics Inc
07/05/2019	17:01	GlobeNewswire Inc.	Novelion Therapeutics Reports First Quarter 2019 Financial Results	NASDAQ:NVLN	Novelion Therapeutics Inc
26/04/2019	10:01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:NVLN	Novelion Therapeutics Inc
31/03/2019	03:00	GlobeNewswire Inc.	Novelion Therapeutics Observes World Lipodystrophy Day	NASDAQ:NVLN	Novelion Therapeutics Inc
29/03/2019	15:29	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:NVLN	Novelion Therapeutics Inc
15/03/2019	17:06	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:NVLN	Novelion Therapeutics Inc
14/03/2019	18:12	GlobeNewswire Inc.	Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results	NASDAQ:NVLN	Novelion Therapeutics Inc